? We propose to use water-soluble synthetic copolymers based on N-(2 hydroxypropyl) methacrylamide (HPMA) as carriers for pharmacologically active molecules. Specifically, we will synthesize an agonistic antibody - i.e. anti-TRAIL receptor (anti-DR4 or anti-DR5)-HPMA copolymer conjugates designed to induce selective apoptotic death in TRAIL-sensitive ovarian cancer cells. The agonistic antibodies resemble the cytokine and death ligand TRAIL. After binding to DR4 and DR5 death receptors they induce selective apoptotic death in a number of different cancer cells, including ovarian cancer cells. In this application, the agonistic antibody serves both as a death-inducing (cytotoxic) molecule and a targeting moiety. ? The development of multiple drug resistance (frequently seen in ovarian carcinoma) is a consequence of conventional cancer chemotherapy and remains the major obstacle in its treatment. Since the drug (doxorubicin) and TRAIL death-signaling pathways cross-sensitize each other, we suggest to use HPMA copolymer conjugates containing two molecules that act in synergy (agonistic anti-DR4 and/or anti-DR5 antibody plus doxorubicin) or HPMA copolymer-bound antibody and HPMA copolymer-bound drug for combination immunochemotherapy. This is intended to overcome both TRAIL- and drug-resistance in ovarian cancer. ? This HPMA copolymer carrier-based therapy should stabilize the agonistic antibody, increase its proapoptotic activity, decrease its immunogenicity, prolong its availability in the blood stream, and allow a dosage reduction, thereby minimizing unwanted side effects while simultaneously enhancing cytotoxicity. ? ? ?

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW006260-03
Application #
7172976
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Program Officer
Primack, Aron
Project Start
2004-12-15
Project End
2007-11-30
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
3
Fiscal Year
2007
Total Cost
$37,928
Indirect Cost
Name
University of Utah
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yang, Jiyuan; Kope?ek, Jind?ich (2016) Design of smart HPMA copolymer-based nanomedicines. J Control Release 240:9-23
Yang, Jiyuan; Kope?ek, Jind?ich (2015) POLYMERIC BIOMATERIALS AND NANOMEDICINES. J Drug Deliv Sci Technol 30:318-330
Kopecek, Jindrich; Kopecková, Pavla (2010) HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev 62:122-49